IT injection of 2′3′-cGAMP also activated a STING-dependent anti-tumour immune response in melanoma and colon cancer models, and in some cases, such treatment synergized with checkpoint inhibitors [58,60]. This evidence concerns the gene STING1 and neoplasm.